GAIN THERAPEUTICS INC (GANX) Institutional Ownership Changes & 13F Activity
GAIN THERAPEUTICS INC (GANX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Susquehanna International Group, Llp, Gsa Capital Partners Llp, Jane Street Group, Llc, Marshall Wace, Llp, and Squarepoint Ops Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +129,624 | +520.6% | 154,524 | $313.68K | Q2 2026 | Sep 02, 2026 |
| Mercer Global Advisors Inc | Buy | +10,000 | — | 10,000 | $20.30K | Q2 2026 | Aug 19, 2026 |
| Susquehanna International Group, Llp | Sell | -353,061 | -81.9% | 78,206 | $158.76K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -161,255 | -74.4% | 55,628 | $112.92K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +136,359 | — | 136,359 | $276.81K | Q2 2026 | Aug 14, 2026 |
| Potomac Capital Management, Inc. | Sell | -62,200 | -6.2% | 946,400 | $1.92M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +55,294 | — | 55,294 | $112.25K | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Sell | -23,023 | -3.6% | 608,592 | $1.07M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Buy | +12,739 | — | 12,739 | $25.86K | Q2 2026 | Aug 14, 2026 |
| Group One Trading Llc | Sell | -2,596 | -40.5% | 3,808 | $7.73K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +2,000 | — | 2,000 | $4.06K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Sell | -1,650 | -14.9% | 9,400 | $19.08K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +1,352 | — | 1,352 | $2.75K | Q2 2026 | Aug 14, 2026 |
| Marshall Wace, Llp | Buy | +153,758 | +8.7% | 1,923,546 | $3.90M | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +80,383 | +20.1% | 480,269 | $974.95K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Sell | -16,984 | -14.9% | 97,013 | $196.94K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -13,680 | -9.8% | 125,972 | $255.72K | Q2 2026 | Aug 13, 2026 |
| Virtu Financial Llc | Buy | +10,330 | +96.7% | 21,015 | $43.00K | Q2 2026 | Aug 13, 2026 |
| Sanctuary Advisors, Llc | Buy | +10,000 | — | 10,000 | $20.30K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -5,477 | -2.5% | 215,012 | $436.48K | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +1,555 | +0.7% | 231,534 | $470.01K | Q2 2026 | Aug 13, 2026 |
| Harbour Investments, Inc. | Buy | +10,745 | — | 10,745 | $21.81K | Q2 2026 | Aug 12, 2026 |
| Geode Capital Management, Llc | Buy | +6,159 | +1.4% | 453,501 | $921.37K | Q2 2026 | Aug 12, 2026 |
| Jpmorgan Chase & Co | Buy | +1,700 | — | 1,700 | $3.37K | Q2 2026 | Aug 12, 2026 |
| Stratos Wealth Partners, Ltd. | Buy | +68,379 | +52.0% | 200,000 | $406.00K | Q2 2026 | Aug 11, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +2,815 | +51.1% | 8,321 | $16.89K | Q2 2026 | Aug 11, 2026 |
| Arax Advisory Partners | Buy | +1,700 | — | 1,700 | $3.45K | Q2 2026 | Aug 10, 2026 |
| Blackrock, Inc. | Buy | +49,911 | +22.2% | 274,957 | $558.16K | Q2 2026 | Aug 07, 2026 |
| Lpl Financial Llc | Buy | +13,000 | +12.5% | 117,251 | $238.02K | Q2 2026 | Aug 07, 2026 |
| Gsa Capital Partners Llp | Buy | +319,664 | +102.3% | 632,131 | $1.28M | Q2 2026 | Aug 06, 2026 |
Frequently asked questions about GANX activity
Which institutional owners are buying GANX?
Institutional owners buying GANX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GANX activity?
"Buy" means an investor increased their reported position in GANX compared to the prior reporting period. This reflects growing exposure to GAIN THERAPEUTICS INC (GANX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GANX increasing?
Institutional interest in GANX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GANX Institutional Insights
- GANX Overview
- GANX 13F Institutional Holders
- GANX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GANX Insider Trading & SEC Form 4 Activity
- GANX Articles
- Top Institutional Investor Stock Rankings